CathConnect develops medical devices focused on improving the safety and efficacy of urinary catheters. Their technology aims to mitigate common complications associated with catheter use, such as urethral trauma. This focus provides clinicians with tools designed to enhance patient care during catheterization procedures.
Funding
$440K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Indwelling urinary catheters, while essential for managing urinary retention and incontinence, frequently cause urethral trauma, leading to pain, bleeding, and increased risk of infection for patients. Current catheter designs lack features to prevent over-inflation of the balloon or improper positioning within the urethra, contributing to these complications.
Solution
CathConnect is developing a novel urinary catheter designed to mitigate urethral trauma and improve patient safety. The device incorporates a mechanism to prevent over-inflation of the catheter balloon, reducing pressure on the urethral walls. The design also focuses on ensuring proper catheter placement, minimizing the risk of injury during insertion and while indwelling. By addressing these key factors, CathConnect aims to reduce the incidence of catheter-associated complications and improve the overall patient experience.
Target Audience
The primary target audience includes hospitals, long-term care facilities, and home healthcare providers who utilize indwelling urinary catheters, as well as the patients who require catheterization.
Features
- Integrated mechanism to prevent over-inflation of the catheter balloon
- Design features to promote proper catheter placement within the urethra
- Materials selected for biocompatibility and reduced friction
- Ergonomic design for ease of insertion and removal